Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
BJS Open2019Vol. 3(5), pp. 646–655
Citations Over Time
Ilaria Pergolini, Stefano Crippa, Michele Pagnanelli, Giulio Belfiori, Alessandro Pucci, Stefano Partelli, Corrado Rubini, M. Paola Castelli, Giuseppe Zamboni, Massimo Falconi
Abstract
Ki-67 index could be of use in predicting the survival of patients with PDAC. Further investigation in larger cohorts is needed to validate these results.
Related Papers
- → Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas(2014)58 cited
- → Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population(2020)26 cited
- → Expression and prognostic value of the Ki-67 in Wilms’ tumor: experience with 48 cases(2010)21 cited
- → Ki-67 proliferative index correlation to the immunohistochemistry profile in early female breast cancer: a review of 515 cases(2021)5 cited
- → Figure S1 from Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification(2023)